ANGPTL8 and metabolic dysfunction-associated steatotic liver disease: To corroborate the human findings regarding the potential involvement of ANGPTL8 in the improvement of NAFLD after bariatric surgery, an experimental model of diet-induced obesity submitted either to sleeve gastrectomy or RYGB was used.